X4 Pharmaceuticals, Inc. (XFOR)
4.22
+0.05
(+1.20%)
USD |
NASDAQ |
Aug 27, 16:00
4.22
0.00 (0.00%)
After-Hours: 20:00
X4 Pharmaceuticals EPS Diluted (TTM) : -1.194 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.194 |
| March 31, 2026 | -4.538 |
| December 31, 2025 | -4.337 |
| September 30, 2025 | -10.01 |
| June 30, 2025 | -9.501 |
| March 31, 2025 | -5.576 |
| December 31, 2024 | -5.876 |
| September 30, 2024 | -0.0853 |
| June 30, 2024 | 0.0857 |
| March 31, 2024 | -0.6969 |
| December 31, 2023 | -0.6027 |
| September 30, 2023 | -0.7953 |
| June 30, 2023 | -1.046 |
| March 31, 2023 | -1.315 |
| December 31, 2022 | -1.868 |
| September 30, 2022 | -2.817 |
| June 30, 2022 | -3.313 |
| March 31, 2022 | -3.454 |
| December 31, 2021 | -4.033 |
| September 30, 2021 | -3.708 |
| June 30, 2021 | -3.818 |
| Date | Value |
|---|---|
| March 31, 2021 | -3.834 |
| December 31, 2020 | -3.093 |
| September 30, 2020 | -2.839 |
| June 30, 2020 | -3.187 |
| March 31, 2020 | -3.447 |
| December 31, 2019 | -9.564 |
| September 30, 2019 | -4570.69 |
| June 30, 2019 | -5181.11 |
| March 31, 2019 | -21199.34 |
| December 31, 2018 | -40310.82 |
| September 30, 2018 | -37565.75 |
| June 30, 2018 | -61366.02 |
| March 31, 2018 | -45361.17 |
| December 31, 2017 | -26256.60 |
| September 30, 2017 | -24842.36 |
| June 30, 2017 | -1110.52 |
| March 31, 2017 | -1486.51 |
| December 31, 2016 | -1481.75 |
| September 30, 2016 | -1079.28 |
| June 30, 2016 | -399.21 |
| March 31, 2016 | -8.827 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Sarepta Therapeutics, Inc. | -2.898 |
| Arrowhead Pharmaceuticals, Inc. | -2.243 |
| Oncolytics Biotech, Inc. | -0.2725 |
| Sangamo Therapeutics, Inc. | -0.383 |
| Anixa Biosciences, Inc. | -0.3032 |